21.05.2024 07:14:58 - dpa-AFX: *FDA GRANTS BREAKTHROUGH STATUS TO GENENTECH'S INAVOLISIB FOR ADVANCED HR+/HER2- BREAST CANCER WITH PIK3CA MUTATION

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ROCHE HLDG AG GEN. 855167 Hamburg 0,000 03.06.24 11:02:37 ±0,000 ±0,00% 0,000 0,000 0,000 245,550

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH